SOPHiA GENETICS to Participate in Fireside Chat at 20th Annual Morgan Stanley Global Healthcare Conference
September 02 2022 - 7:00AM
SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company
in the healthcare space, announced today Chief Executive Officer,
Dr. Jurgi Camblong and Chief Financial Officer, Ross Muken will
participate in a fireside chat at the 20th Annual Morgan Stanley
Global Healthcare Conference on Monday, September 12, 2022, at 8:45
a.m. EDT.
About SOPHiA GENETICSSOPHiA GENETICS (Nasdaq:
SOPH) is a software company dedicated to establishing the practice
of data-driven medicine as the standard of care and for life
sciences research. It is the creator of the SOPHiA DDM™ Platform, a
cloud-native platform capable of analyzing data and generating
insights from complex multimodal data sets and different diagnostic
modalities. The SOPHiA DDM™ Platform and related solutions,
products and services are currently used by a broad network of
hospital, laboratory, and biopharma institutions globally. For more
information, visit SOPHiAGENETICS.COM, or connect on Twitter,
LinkedIn and Instagram. Where others see data, we see
answers
Investor Contact:Jennifer PottageHead of
Investor Relationsir@sophiagenetics.com
Media Contact:Kelly KatapodisSenior Manager,
Media & Communicationsmedia@sophiagenetics.com
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Jul 2023 to Jul 2024